FDA “Undercuts” NDI Guidance Opposition With Compliance Cost Estimate – CRN
This article was originally published in The Tan Sheet
Executive Summary
OMB approves FDA’s estimate as the official measure for the supplement industry’s anticipated burden in complying with the NDI notification regulation.